CR20120592A - Intermedios de agomelatina y métodos de preparación de estos - Google Patents
Intermedios de agomelatina y métodos de preparación de estosInfo
- Publication number
- CR20120592A CR20120592A CR20120592A CR20120592A CR20120592A CR 20120592 A CR20120592 A CR 20120592A CR 20120592 A CR20120592 A CR 20120592A CR 20120592 A CR20120592 A CR 20120592A CR 20120592 A CR20120592 A CR 20120592A
- Authority
- CR
- Costa Rica
- Prior art keywords
- preparation
- methods
- agomelatin
- intermediates
- agomelatine
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 239000000543 intermediate Substances 0.000 title 1
- YJYPHIXNFHFHND-UHFFFAOYSA-N agomelatine Chemical compound C1=CC=C(CCNC(C)=O)C2=CC(OC)=CC=C21 YJYPHIXNFHFHND-UHFFFAOYSA-N 0.000 abstract 2
- 229960002629 agomelatine Drugs 0.000 abstract 2
- 229940126062 Compound A Drugs 0.000 abstract 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/06—Preparation of carboxylic acid amides from nitriles by transformation of cyano groups into carboxamide groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/22—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Battery Electrode And Active Subsutance (AREA)
Abstract
La presente invención se refiere a los compuestos intermedios para la preparación de agomelatina, así como a los métodos de preparación de estos. El intermedio de la presente invención para la preparación de agomelatina es el compuesto A como se muestra en la formula siguiente.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101973700A CN102276492B (zh) | 2010-06-08 | 2010-06-08 | 阿戈美拉汀中间体及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR20120592A true CR20120592A (es) | 2013-03-04 |
Family
ID=45097542
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR20120592A CR20120592A (es) | 2010-06-08 | 2012-11-22 | Intermedios de agomelatina y métodos de preparación de estos |
Country Status (41)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012046253A2 (en) * | 2010-10-08 | 2012-04-12 | Msn Laboratories Limited | Process for the preparation of n-[2- (7-methoxy-l-naphthyl) ethyl] acetamide and its novel crystalline forms |
| CN102452951B (zh) * | 2010-10-25 | 2014-02-19 | 天津泰普药品科技发展有限公司 | 阿戈美拉汀及其药物组合物 |
| ITMI20121444A1 (it) | 2012-08-27 | 2014-02-28 | Procos Spa | Processo per la produzione di agomelatine |
| WO2014056421A1 (zh) * | 2012-10-09 | 2014-04-17 | 江西同和药业有限责任公司 | 1-氰基-1-（7-甲氧基-1-萘基）甲醇酯类化合物及其制备方法和应用 |
| CN112574066B (zh) * | 2019-09-27 | 2024-10-25 | 江苏豪森药业集团有限公司 | 一种阿戈美拉汀中间体的制备方法 |
| BR112022012342A2 (pt) * | 2019-12-23 | 2022-09-06 | Dsm Ip Assets Bv | Processo de desidrogenação |
| CN117964510B (zh) * | 2024-01-31 | 2026-05-19 | 浙江东亚药业股份有限公司 | 一种阿戈美拉汀的制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2658818B1 (fr) * | 1990-02-27 | 1993-12-31 | Adir Cie | Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| DE10229842A1 (de) | 2002-07-03 | 2004-02-05 | Helmut Prof. Dr. Schmidhammer | Morphinanderivate und deren quartäre Ammoniumsalze substituiert in Position 14, Herstellungsverfahren und Verwendung |
| FR2866335B1 (fr) | 2004-02-13 | 2006-05-26 | Servier Lab | Nouveau procede de synthese de l'agomelatine |
| FR2866336B1 (fr) * | 2004-02-13 | 2006-03-24 | Servier Lab | Nouveau procede de synthese du (7-methoxy-3,4-dihydro-1-naphtalenyl) acetonitrile et application a la synthese de l'agomelatine |
| FR2866334B1 (fr) * | 2004-02-13 | 2006-05-26 | Servier Lab | Nouveau procede de synthese du (7-methoxy-1-naphtyl) acetonitrile et application a la synthese de l'agomelatine |
| MX2008015843A (es) * | 2006-06-20 | 2009-01-09 | Hoffmann La Roche | Derivados de tetralina e indano y usos de los mismos. |
| CN101486665B (zh) * | 2009-03-03 | 2013-04-17 | 上海医药工业研究院 | 阿戈美拉汀中间体2-(7-甲氧基-1-萘基)乙酰胺的制备方法 |
| WO2012093402A1 (en) * | 2011-01-04 | 2012-07-12 | Symed Labs Limited | Processes for the preparation of n-[2-(7-methoxy-1-naphthyl)ethyl]acetamide |
-
2010
- 2010-06-08 CN CN2010101973700A patent/CN102276492B/zh not_active Expired - Fee Related
-
2011
- 2011-06-08 NO NO11791930A patent/NO2580189T3/no unknown
- 2011-06-08 JP JP2013513535A patent/JP5519863B2/ja not_active Expired - Fee Related
- 2011-06-08 LT LTEP11791930.8T patent/LT2580189T/lt unknown
- 2011-06-08 CA CA2801822A patent/CA2801822C/en not_active Expired - Fee Related
- 2011-06-08 BR BR112012031086-0A patent/BR112012031086B1/pt not_active IP Right Cessation
- 2011-06-08 KR KR1020137000375A patent/KR101470874B1/ko not_active Expired - Fee Related
- 2011-06-08 MA MA35423A patent/MA34292B1/fr unknown
- 2011-06-08 AU AU2011264206A patent/AU2011264206B2/en not_active Ceased
- 2011-06-08 SG SG2012085296A patent/SG185667A1/en unknown
- 2011-06-08 DK DK11791930.8T patent/DK2580189T3/da active
- 2011-06-08 EA EA201201666A patent/EA020271B1/ru unknown
- 2011-06-08 GE GEAP201112941A patent/GEP20156234B/en unknown
- 2011-06-08 EP EP11791930.8A patent/EP2580189B1/en active Active
- 2011-06-08 ME MEP-2018-6A patent/ME02992B/me unknown
- 2011-06-08 PE PE2012002205A patent/PE20130252A1/es active IP Right Grant
- 2011-06-08 MY MYPI2012700965A patent/MY160954A/en unknown
- 2011-06-08 PH PH1/2012/502275A patent/PH12012502275A1/en unknown
- 2011-06-08 HR HRP20171751TT patent/HRP20171751T1/hr unknown
- 2011-06-08 US US13/702,388 patent/US8779199B2/en not_active Expired - Fee Related
- 2011-06-08 NZ NZ604081A patent/NZ604081A/en not_active IP Right Cessation
- 2011-06-08 WO PCT/CN2011/075438 patent/WO2011153939A1/en not_active Ceased
- 2011-06-08 AP AP2013006659A patent/AP3205A/xx active
- 2011-06-08 MX MX2012013870A patent/MX2012013870A/es active IP Right Grant
- 2011-06-08 PL PL11791930T patent/PL2580189T3/pl unknown
- 2011-06-08 ES ES11791930.8T patent/ES2656968T3/es active Active
- 2011-06-08 PT PT117919308T patent/PT2580189T/pt unknown
- 2011-06-08 SI SI201131371T patent/SI2580189T1/en unknown
- 2011-06-08 HU HUE11791930A patent/HUE035850T2/en unknown
- 2011-06-08 RS RS20171239A patent/RS56659B1/sr unknown
- 2011-06-08 UA UAA201300117A patent/UA104684C2/ru unknown
- 2011-06-08 CU CU20120163A patent/CU24148B1/es active IP Right Grant
-
2012
- 2012-11-21 ZA ZA2012/08764A patent/ZA201208764B/en unknown
- 2012-11-21 TN TNP2012000542A patent/TN2012000542A1/en unknown
- 2012-11-22 IL IL223180A patent/IL223180A/en active IP Right Grant
- 2012-11-22 CR CR20120592A patent/CR20120592A/es unknown
- 2012-11-30 NI NI201200177A patent/NI201200177A/es unknown
- 2012-11-30 CL CL2012003371A patent/CL2012003371A1/es unknown
- 2012-12-07 EC ECSP12012328 patent/ECSP12012328A/es unknown
- 2012-12-07 GT GT201200328A patent/GT201200328A/es unknown
-
2018
- 2018-01-22 CY CY20181100076T patent/CY1119857T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020010330A (es) | Proceso para preparar un compuesto antiviral de formula i. | |
| CR20130129A (es) | Anàlogos de buprenorfina | |
| CR20140237A (es) | Procedimiento de preparación de 5-fluoro-1h-pirazolopiridinas sustituidas | |
| IN2014MN02496A (es) | ||
| CR20140042A (es) | Indazoles | |
| UY32142A (es) | Preparación de una quinoliniloxidifenilciclopropanodicarboxamida | |
| MX2019003738A (es) | Compuestos antivirales. | |
| CO6771439A2 (es) | Inhibidores de benzodioxano de la producción de leucotrieno | |
| CR20200276A (es) | Sulfamoilarilamidas y su uso como medicamentos para el tratamientos de la hepatitis b (divisional exp. 2015-0059) | |
| CR20140510A (es) | Nucleósidos de espirooxetano de uracilo | |
| ECSP12011581A (es) | Inhibidores de bace | |
| CO6491116A2 (es) | Derivados de 5-fluoropirimidinona | |
| EA201490474A1 (ru) | Аминохиназолины в качестве ингибиторов киназ | |
| CR20120513A (es) | HETEROARIL-CICLOHEXIL-TETRAAZABENZO [e] AZULENOS | |
| IN2014KN01491A (es) | ||
| CR20140094A (es) | Derivados de etinilo | |
| CR20140435A (es) | Nuevos derivados de tienopirimidina, procesos para su preparacion y sus usos terapeuticos | |
| CR20140322A (es) | Nuevos derivados de bencil sulfonamida útiles como inhibidores de mogat-2 | |
| CR20150245A (es) | Proceso novedoso para la elaboración de compuestos para uso en el tratamiento de cáncer | |
| CR20150084A (es) | 2-oxo-2,3-dihidro-indoles | |
| IN2014DN00144A (es) | ||
| CR20150087A (es) | Derivados de pirazol-carboxamida | |
| CR20130597A (es) | Isoxazolinas como agentes terapèuticos | |
| GT201200328A (es) | Intermedios de agomelatina y método de preparación de éstos | |
| CO6751286A2 (es) | Síntesis de derivados de 2-carboxamida-cicloamino-urea |